Biological AI is our patented approach to humanizing AI. It unites the power of Cognitive Modeling with Embodied Cognition, creating an interactive, empathetic Digital Person that can understand and react to real people and the real world.

We use our patented Biological AI technology to reimagine the customer experience, drive interactivity, and create personalized digital engagement. Only Soul Machines delivers the full capabilities of human and machine collaboration in an ethical, responsive, and unprecedented way. Our revolutionary Soul Machines Studio software and Human OS cloud platform allow anyone to create hyper-human, autonomous Digital People, powered by our patented Digital Brain

Soul Machines has raised a total of $119.5 million over 5 rounds. Their latest funding round was a Series B – II for $70 million on February 14, 2022. The company has 11 investors, including Horizons Ventures, which invested in Soul Machines’ Series B – II funding round. The company’s deal structure is available for 1 funding round, including their Series A from November 22, 2016. Soul Machines’ revenue sources are not provided in the search results.